Preliminary scientific tests suggest conolidine may well inhibit certain ion channels, lowering neuronal excitability and restricting ache indicators. This mechanism is particularly relevant in neuropathic suffering, in which abnormal signaling causes persistent pain. Also, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integ